Glow – TB-500 10mg / BPC-157 10mg / GHK-Cu 50mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Glow supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF102025041

Key analytical results include:

• Total Peptide Content: 70 mg blend
• Identification – Retention Time: confirmed
• Identification – Spectrum: confirmed
• Purity: greater than 99 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Glow is a multi-peptide research formulation combining BPC-157, GHK-Cu and TB-500 in a single lyophilized compound preparation designed for experimental biochemical research.

The formulation combines three peptide compounds frequently studied in laboratory environments exploring cellular signalling, extracellular matrix regulation and peptide-mediated tissue biology pathways.

This preparation contains 70 mg of high purity lyophilized peptide blend supplied in a sealed research vial. Lyophilization preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of the defined peptide composition and stable analytical profile, the Glow formulation is frequently referenced in experimental peptide signalling and cellular biology research models.

Compound Overview

The Glow formulation contains three peptides commonly investigated in biochemical and cellular signalling research:

• BPC-157 – a synthetic pentadecapeptide derived from a protective protein sequence studied in experimental tissue signalling models.
• GHK-Cu – a copper-binding tripeptide complex investigated for its interaction with extracellular matrix signalling and peptide-mediated regulatory pathways.
• TB-500 – a synthetic peptide fragment derived from thymosin beta-4 studied in experimental models examining cellular migration and signalling mechanisms.

Each peptide in this formulation is investigated in laboratory settings examining peptide-mediated signalling pathways and cellular regulatory processes.

Historical Background and Scientific Context

Scientific interest in peptide signalling pathways increased rapidly during the late twentieth century as molecular biology and peptide synthesis technologies advanced.

During this period researchers identified several biologically active peptide fragments involved in cellular communication and regulatory signalling.

Compounds such as BPC-157, GHK-Cu and thymosin-derived peptides were subsequently investigated in experimental biochemical research exploring extracellular signalling networks and cellular regulatory systems.

Modern research frequently utilises peptide blends and comparative peptide models to investigate complex signalling pathways and cellular regulatory interactions.

Mechanistic Focus in Research

Within controlled laboratory environments, Glow may be studied in relation to peptide-mediated signalling networks and cellular regulatory systems.

Experimental research models frequently explore:

• Peptide-mediated cellular signalling pathways
• Extracellular matrix regulatory mechanisms
• Cellular migration and communication systems
• Peptide interaction networks
• Comparative peptide pathway modelling
• Intracellular regulatory signalling
• Peptide-based molecular research models

These experimental systems allow researchers to explore complex biochemical signalling interactions between multiple peptide compounds.

Research Applications

In controlled research environments, Glow may be utilised in experimental models designed to explore peptide signalling and cellular regulatory systems.

Examples of research applications include:

• Peptide signalling pathway investigation
• Cellular communication research
• Extracellular matrix biology studies
• Comparative peptide compound evaluation
• Cell signalling network modelling
• Multi-peptide interaction research
• Controlled in vitro peptide studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity for all three peptides
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF082025011 – Published September 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.